These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15423685)

  • 21. Phenacemide in treatment of epilepsy.
    TYLER MW; KING EQ
    J Am Med Assoc; 1951 Sep; 147(1):17-21. PubMed ID: 14861009
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenurone in the treatment of psychomotor attacks.
    DeJONG RN
    Am J Psychiatry; 1951 May; 107(11):825-31. PubMed ID: 14829606
    [No Abstract]   [Full Text] [Related]  

  • 23. Stereochemical similarities in chemically different antiepileptic drugs.
    Camerman A; Camerman N
    Adv Neurol; 1980; 27():223-31. PubMed ID: 6103657
    [No Abstract]   [Full Text] [Related]  

  • 24. [Value of 3-methyl-5, 5-phenyl-ethyl-hydantoin in therapy of epilepsy].
    HOLTZER PA
    Belg Tijdschr Geneesk; 1952 Sep; 8(18):817-31. PubMed ID: 13008950
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of phenacemide in epilepsy, with analysis of fatal reactions and case report.
    CRADDOCK WL
    J Am Med Assoc; 1955 Dec; 159(15):1437-41. PubMed ID: 13271091
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of phenylacetylurea (phenurone) in convulsive disorders.
    LITTLE SC; McBRYDE RR
    Am J Med Sci; 1950 May; 219(5):494-99. PubMed ID: 15410710
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical tests of a new anti-epileptic drug: phenylacetylurea].
    FURTADO D
    J Med (Oporto); 1955 Dec; 28(671):727-36. PubMed ID: 13278123
    [No Abstract]   [Full Text] [Related]  

  • 28. Fatal hepatorenal syndrome associated with phenurone therapy.
    LEVY RW; SIMONS DJ; ARONSON S
    N Engl J Med; 1950 Jun; 242(24):933-6. PubMed ID: 15423683
    [No Abstract]   [Full Text] [Related]  

  • 29. PEGANONE, new antiepileptic.
    Whats New; 1957; (200):3-5. PubMed ID: 24544510
    [No Abstract]   [Full Text] [Related]  

  • 30. Peganone, a new antiepileptic drug.
    SCHWADE ED; RICHARDS RK; EVERETT GM
    Dis Nerv Syst; 1956 May; 17(5):155-8. PubMed ID: 13317788
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of phenurone in convulsive disorders in children.
    KEITH HM
    AMA Am J Dis Child; 1950 Nov; 80(5):719-24. PubMed ID: 14777153
    [No Abstract]   [Full Text] [Related]  

  • 32. [First clinical experiences with a new phenuron derivative in therapy-resistant epileptics].
    KRAUSE G; FOERSTER W
    Psychiatr Neurol Med Psychol (Leipz); 1961 Jul; 13():270-3. PubMed ID: 13754081
    [No Abstract]   [Full Text] [Related]  

  • 33. [ON SOME ASPECTS OF EPILEPSY AND THE EFFECT OF ANTICONVULSANTS].
    GEORGIEV VP
    Suvr Med (Sofiia); 1963; 14():38-44. PubMed ID: 14103134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Our experiences in the treatment of epilepsy with methyl-phenyl-ethyl-hydantoin].
    ROGER J; ROGER A
    Prog Med (Paris); 1958 Feb; 86(4):67. PubMed ID: 13527523
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical evaluation of 1-methyl-5,5-phenyl-ethyl-hydantoin in the treatment of epilepsy.
    LIVINGSTON S; PAULI LL; KRAMER I; NAJMABADI A
    N Engl J Med; 1961 Aug; 265():418-21. PubMed ID: 13762831
    [No Abstract]   [Full Text] [Related]  

  • 36. [EFFECT OF ANTICONVULSANT DRUGS ON HEMATOPOIESIS].
    DIESKA D; GAJDOS M
    Cas Lek Cesk; 1964 Aug; 103():961-5. PubMed ID: 14190563
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lymph node manifestations during methyl-phenyl-ethyl-hydantoin therapy].
    OLMER J; PAILLAS J; ROGER J; MURATORE R; BADIER M
    Presse Med (1893); 1952 Dec; 60(82):1748-50. PubMed ID: 13027182
    [No Abstract]   [Full Text] [Related]  

  • 38. Epilepsy; treatment with new drug; 3-methyl 5,5-phenyl-ethyl-hydantoin (phenantoin).
    KOZOL HL
    Am J Psychiatry; 1946 Sep; 103(2):154-8. PubMed ID: 21001983
    [No Abstract]   [Full Text] [Related]  

  • 39. [General review of the toxic side-effects caused by hydantoin derivatives used in epilepsy].
    FACCHETTI G
    Cervello G Nevrol; 1962 Mar; 38():147-60. PubMed ID: 13891254
    [No Abstract]   [Full Text] [Related]  

  • 40. [ANTI-EPILEPSY DRUGS].
    FURNADZHIEV GP
    Suvr Med (Sofiia); 1963; 14():46-55. PubMed ID: 14103144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.